Calgary Registry for Advanced and Therapeutic Endoscopy
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity of Calgary
About this trial
The aim of the Calgary Registry for Advanced and Therapeutic Endoscopy (CReATE) is to be a high-fidelity prospective multi-centre registry. The study population consists of consecutive adult ERCP patients from September 2018 to August 2022. Informed consent is acquired for each patient. All relevant pre-procedural, procedural, peri-procedural and post-procedural data are captured in real time by a full-time third-party research assistant directly observing procedures. Outcomes are ascertained by comprehensive medical record review and patient phone interview 30 days after the index procedure. This registry also serves as a secure data collection platform for several currently recruiting prospective studies and randomized trials.
Eligibility criteria
Qualifiers
any standard indication for ERCP, in the absence of standard contraindications;
age 18 years or over;
ability and willingness to give informed consent to be included in the registry and/or to involvement in one (or more) prospective sub-studies, or accompaniment by a surrogate who is willing and able to provide consent.
Disqualifiers
None
Trial design
Treatments tested in this trial
- Endoscopic retrograde pancreatography (ERCP)
Treatment groups
No treatment groups listed
Sponsors and collaborators
Source ClinicalTrials.gov